| Dr Ana Cecilia Belzarena Genovese, MD | |
|
204 N Keene St Ste 102, Columbia, MO 65201-8136 | |
| (573) 884-7874 | |
| (573) 884-9898 |
| Full Name | Dr Ana Cecilia Belzarena Genovese |
|---|---|
| Gender | Female |
| Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
| Location | 204 N Keene St Ste 102, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982159810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2022048727 (Missouri) | Secondary |
| 207XP3100X | Orthopaedic Surgery - Pediatric Orthopaedic Surgery | 2022048727 (Missouri) | Primary |
| Entity Name | Capital Region Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477980837 PECOS PAC ID: 4688573686 Enrollment ID: O20070323000507 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Drugs widely prescribed for attention disorders like Ritalin, Adderall and other drugs, did not increase the risk of serious heart problems in a major study published Monday. This could assure parents of children on these medications on heart-related safety of the medicines.
For someone recovering from severe burns, eating is often the last thing they want to do. However, burn specialists at The Ohio State University Wexner Medical Center say nutrition is so vital to their patients' recovery that they make it a quality indicator for patient care.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
› Verified 5 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Drugs widely prescribed for attention disorders like Ritalin, Adderall and other drugs, did not increase the risk of serious heart problems in a major study published Monday. This could assure parents of children on these medications on heart-related safety of the medicines.
For someone recovering from severe burns, eating is often the last thing they want to do. However, burn specialists at The Ohio State University Wexner Medical Center say nutrition is so vital to their patients' recovery that they make it a quality indicator for patient care.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ana Cecilia Belzarena Genovese, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Ana Cecilia Belzarena Genovese, MD 204 N Keene St Ste 102, Columbia, MO 65201-8136 Ph: (573) 884-7874 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.
Lawmakers, patient-privacy and health care advocates, and information technology experts on Tuesday "debated ... how Congress can strike a balance between accelerating the adoption of a nationwide system of electronic medical records while protecting patient privacy," CongressDaily reports (Noyes, CongressDaily, 6/4).
Drugs widely prescribed for attention disorders like Ritalin, Adderall and other drugs, did not increase the risk of serious heart problems in a major study published Monday. This could assure parents of children on these medications on heart-related safety of the medicines.
For someone recovering from severe burns, eating is often the last thing they want to do. However, burn specialists at The Ohio State University Wexner Medical Center say nutrition is so vital to their patients' recovery that they make it a quality indicator for patient care.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a fourth allotment, of 54 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol.
› Verified 5 days ago
Prati Jahnu Reddy, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1100 Virginia Ave, Columbia, MO 65212 Phone: 573-882-2663 | |
Randal R Trecha, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1 S Keene St, Columbia, MO 65201 Phone: 573-443-2402 Fax: 573-443-0574 | |
Gregory John Della Rocca, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2663 Fax: 573-882-0569 | |
Daniel A London, MD, MS Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Virginia Ave, Columbia, MO 65212 Phone: 573-882-2663 Fax: 573-882-1760 | |
Adam Mohamed Fahs, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-2663 Fax: 573-882-1760 | |
Levi Nathan Gause, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Virginia Ave, Columbia, MO 65212 Phone: 573-882-2663 Fax: 573-882-1760 | |
Tzu Chuan Yen, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1100 Virginia Ave, Columbia, MO 65201 Phone: 573-882-2663 |